Profil
Achi Ludomirsky is the founder of Ultrasight.
He held the title of Chief Medical Officer at the company.
Postes actifs de Achi Ludomirsky
| Sociétés | Poste | Début |
|---|---|---|
Ultrasight
 Ultrasight Packaged SoftwareTechnology Services Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Ultrasight
Ultrasight Packaged SoftwareTechnology Services Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020. | Technology Services |
